Related Experiment Videos
Leiomyosarcoma of the vulva. A case report
1Department of Gynecology and Obstetrics, St. Pölten Hospital, St. Pölten, Austria.
The Journal of Reproductive Medicine
|July 10, 2001
Summary
This study investigated vulvar leiomyosarcoma, a rare tumor. Immunohistochemistry confirmed a low-grade tumor, aiding prognosis and treatment planning.
Area of Science:
- Gynecologic Oncology
- Surgical Pathology
- Immunohistochemistry
Background:
- Vulvar leiomyosarcoma is a rare mesenchymal neoplasm.
- Understanding its biologic features is crucial for patient management.
- Immunohistochemical analysis aids in grading and prognosis.
Observation:
- A 38-year-old woman presented with a slowly growing vulvar mass.
- Diagnosis of low-grade vulvar leiomyosarcoma was confirmed.
- Extensive immunohistochemical staining was performed on tumor tissue.
Findings:
- The tumor expressed estrogen, progesterone, and androgen receptors.
- Moderate Ki-67 proliferation index and absence of p53 overexpression were noted.
- Adequate microvessel density and no lymphatic infiltration suggested a less aggressive phenotype.
Implications:
- The immunohistologic profile supports a low histologic grade.
- These findings are valuable for estimating prognosis.
- The results informed the decision to forgo adjuvant therapy, with no recurrence at 24 months.